| Title |
Anticoagulation for cerebral venous sinus thrombosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2011
|
| DOI | 10.1002/14651858.cd002005.pub2 |
| Pubmed ID | |
| Authors |
Jonathan Coutinho, Sebastiaan FTM de Bruijn, Gabrielle deVeber, Jan Stam |
| Abstract |
Treatment of cerebral venous sinus thrombosis with anticoagulants has been controversial. Anticoagulants may prevent new venous infarcts, neurologic deterioration and pulmonary embolism but may also promote haemorrhages. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 27% |
| Canada | 4 | 27% |
| United Kingdom | 1 | 7% |
| United States | 1 | 7% |
| Unknown | 5 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 47% |
| Practitioners (doctors, other healthcare professionals) | 5 | 33% |
| Scientists | 3 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 195 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 27 | 14% |
| Student > Bachelor | 27 | 14% |
| Researcher | 23 | 12% |
| Student > Doctoral Student | 16 | 8% |
| Other | 15 | 8% |
| Other | 41 | 21% |
| Unknown | 48 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 53% |
| Neuroscience | 14 | 7% |
| Nursing and Health Professions | 11 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 1% |
| Psychology | 2 | 1% |
| Other | 9 | 5% |
| Unknown | 55 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2021.
All research outputs
#3,075,357
of 25,711,518 outputs
Outputs from Cochrane database of systematic reviews
#5,774
of 13,134 outputs
Outputs of similar age
#14,997
of 132,313 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 109 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,313 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.